Study guide
5.3 Seizures, Movement Disorders & Neurodegeneration
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
5.3 Seizures, Movement Disorders & Neurodegeneration
Key Takeaways Explain This Topic AI
Focal seizures begin in a restricted cortical network; generalized seizures engage bilateral networks from onset—secondary generalization is focal onset that later bilaterally propagates.
Status epilepticus is a prolonged or recurrent seizure state without recovery that risks neuronal injury from excitotoxic and metabolic failure; acute management concepts follow from stopping runaway synchronous firing.
Antiepileptic mechanisms cluster as voltage-gated Na+ channel use-dependent block, GABA potentiation, Ca2+ channel modulation (absence/T-type), and synaptic vesicle protein targeting—map drug class to channel/synapse, not brand names alone.
Parkinson disease loses nigrostriatal dopamine; Huntington disease is CAG-repeat degeneration of caudate/putamen; Wilson disease is copper toxicity with basal ganglia injury; ALS combines upper and lower motor neuron degeneration.
Alzheimer disease centers on Aβ plaques and tau neurofibrillary tangles with cholinergic basal forebrain loss; frontotemporal syndromes target frontal/temporal networks; prion disease is templated protein misfolding with rapid spongiform change.
Last updated: August 2026
Seizure Physiology: Focal vs Generalized Networks
A seizure is a transient episode of abnormal, excessive, or synchronous neuronal activity. Epilepsy is a tendency toward recurrent unprovoked seizures. At the membrane level, seizures reflect an imbalance favoring excitation (glutamatergic AMPA/NMDA signaling, inward Na+/Ca2+ currents) over inhibition (GABAergic Cl− currents, outward K+ currents, and various neuromodulators).
Focal (partial) seizures originate within networks limited to one hemisphere. Clinical features follow the cortical region: motor cortex → clonic jerking of a body part (Jacksonian march as adjacent homunculus is recruited); temporal lobe → aura, automatisms, impaired awareness; occipital → visual phenomena. Awareness may be retained (formerly simple partial) or impaired (formerly complex partial) depending on network spread. EEG and semiology localize the onset zone for mechanism-based reasoning.
Generalized seizures engage bilateral distributed networks from the start. Absence seizures show brief behavioral arrest with classic 3-Hz spike-and-wave discharges from thalamocortical oscillatory circuits involving T-type calcium channels . Generalized tonic–clonic seizures produce bilateral stiffening then rhythmic jerking with postictal suppression. Myoclonic seizures are brief shock-like jerks from cortical or cortical–subcortical hypersynchrony.
Secondary generalization begins focally then propagates to bilaterally synchronized networks—important when auras or unilateral features precede bilateral convulsions.
Provoked seizures can arise from hyponatremia, hypoglycemia, alcohol withdrawal (GABA downregulation/NMDA upregulation rebound), high fever in children (febrile seizure physiology), meningitis/encephalitis, or acute stroke—metabolic and structural triggers that lower seizure threshold without defining chronic epilepsy by themselves.
Status Epilepticus Concept
Status epilepticus is continuous seizure activity or recurrent seizures without full recovery of consciousness between them for a prolonged period (operational definitions exist clinically; boards emphasize the dangerous, self-sustaining state). Ongoing glutamate excitotoxicity, calcium overload, energy failure, and blood–brain barrier stress injure neurons. Systemic complications include hypoxia, acidosis, rhabdomyolysis, and autonomic instability. Mechanism-based acute therapy concepts aim to enhance inhibition (benzodiazepines at GABA-A receptors) and then stabilize membranes with longer-acting agents that often block Na+ channels or broaden inhibitory tone—details of protocols matter less than receptor targets for CBSE.
Antiepileptic Drug Mechanisms
Map major mechanistic classes rather than exhaustive brand lists:
Mechanism class Physiologic effect Prototype teaching drugs
Voltage-gated Na+ channel block (use-dependent) Reduces repetitive high-frequency firing Phenytoin, carbamazepine, lamotrigine, lacosamide-related concepts
GABA-A potentiation Increases inhibitory Cl− current Benzodiazepines, barbiturates; valproate has multiple actions including GABA enhancement
T-type Ca2+ channel block Suppresses thalamocortical absence rhythms Ethosuximide (absence-focused teaching)
Broad / mixed (Na+, GABA, other) Multiple stabilizing effects Valproate, topiramate (also carbonic anhydrase/other)
SV2A modulation Alters neurotransmitter vesicle release Levetiracetam class
Use-dependent Na+ channel blockers preferentially bind channels in inactivated states during rapid firing—explaining selectivity for epileptic discharges over normal low-frequency activity. Ethosuximide’s T-type Ca2+ blockade explains absence seizure efficacy via thalamocortical rhythm interruption. Benzodiazepines increase GABA-A channel opening frequency (barbiturates increase duration)—both raise inhibitory tone. Enzyme-inducing AEDs and teratogenicity themes appear in pharmacology integration but mechanism first remains Na+/GABA/Ca2+/SV2A.
Parkinson Disease: Nigrostriatal Dopamine Loss
Parkinson disease (PD) is a progressive neurodegenerative disorder with preferential loss of dopaminergic neurons in the substantia nigra pars compacta projecting to the striatum (nigrostriatal pathway). Lewy bodies (α-synuclein aggregates) are the pathologic hallmark. Dopamine depletion alters basal ganglia circuitry: the direct pathway (facilitate movement) is underactivated and the indirect pathway (inhibit movement) is relatively overactive in classic models, yielding net bradykinesia , rigidity, resting tremor, and postural instability. Lewy pathology also involves extranigral sites, explaining nonmotor features (anosmia, REM sleep behavior disorder, autonomic dysfunction) that may precede motor signs.
Pharmacologic restoration concepts: levodopa crosses BBB and is converted to dopamine; dopamine agonists stimulate striatal receptors; MAO-B or COMT inhibition prolongs dopamine availability; anticholinergics historically modulate the relative ACh excess in striatum. On–off fluctuations and dyskinesias relate to nonphysiologic pulsatile dopaminergic stimulation—mechanism of chronic therapy limits, not dosing recipes.
Huntington Disease, Wilson Disease, and ALS
Huntington disease is autosomal dominant CAG trinucleotide repeat expansion in the HTT gene (polyglutamine). Anticipation with paternal transmission is a classic genetics pearl. Degeneration is severe in the caudate and putamen (striatum), with cortical involvement later. Loss of striatal neurons disrupts basal ganglia balance toward chorea , psychiatric changes, and dementia. GABA-ergic medium spiny neuron loss is a teaching focus; ventriculomegaly with caudate atrophy appears on imaging concepts.
Wilson disease is autosomal recessive copper transport defect ( ATP7B ), impairing biliary copper excretion and ceruloplasmin incorporation. Copper deposits in liver (hepatitis/cirrhosis), cornea (Kayser–Fleischer rings), and basal ganglia (especially putamen) produce a mixed movement disorder (wing-beating tremor, dystonia, parkinsonism) plus psychiatric and hepatic disease. Mechanism: toxic free copper causing oxidative injury—not primary synucleinopathy.
Amyotrophic lateral sclerosis (ALS) combines upper motor neuron (cortex/corticospinal: spasticity, hyperreflexia, Babinski) and lower motor neuron (anterior horn/brainstem nuclei: atrophy, fasciculations, weakness) degeneration. Sensation is typically spared early—key negative finding. Pathologic themes include protein aggregation (TDP-43 in many sporadic cases), excitotoxicity, and oxidative stress hypotheses. Familial subsets involve SOD1, C9orf72 hexanucleotide repeat, and other genes—mechanism diversity under a shared motor neuron phenotype.
- Disease Core locus / molecule Motor phenotype theme
- Parkinson SNpc dopamine; α-synuclein Hypokinetic (bradykinesia, rigidity, rest tremor)
- Huntington CAG HTT ; caudate/putamen Hyperkinetic chorea + cognitive/psychiatric
- Wilson ATP7B copper toxicity; basal ganglia/liver Mixed movement + hepatic/corneal copper
- ALS UMN + LMN degeneration Progressive weakness without early sensory loss
- Alzheimer Disease, Frontotemporal Degeneration, and Prion Disease
Alzheimer disease (AD) is the most common neurodegenerative dementia. Core histopathology: extracellular amyloid-β (Aβ) plaques from APP processing (β- and γ-secretase generating Aβ peptides that aggregate) and intracellular hyperphosphorylated tau neurofibrillary tangles. Synaptic failure and neuronal loss concentrate early in medial temporal/entorhinal–hippocampal circuits (memory encoding) then spread to association cortices. Nucleus basalis of Meynert cholinergic neuron loss reduces cortical acetylcholine—basis for cholinesterase inhibitor concepts. ApoE ε4 is the major genetic risk allele for late-onset disease (impaired Aβ clearance themes). Early-onset familial forms involve APP or presenilin (γ-secretase component) mutations that increase pathogenic Aβ species—high-yield molecular linkage.
Frontotemporal lobar degeneration (FTLD) / frontotemporal dementia syndromes preferentially affect frontal and/or anterior temporal lobes. Behavioral variant FTD: disinhibition, apathy, loss of empathy, compulsive behaviors from orbitofrontal/medial frontal network failure. Primary progressive aphasias reflect dominant language network degeneration. Proteinopathies include tau or TDP-43 (and less often FUS) aggregates—different molecular species than pure Aβ-plaque AD, explaining younger onset and personality/language-first presentations rather than isolated amnestic onset.
Prion diseases (Creutzfeldt–Jakob disease and related) are caused by templated misfolding of prion protein (PrPSc) that converts normal PrPC into pathologic conformers—protein-only transmission concept. Rapidly progressive dementia, myoclonus, cerebellar and pyramidal signs, and spongiform change (vacuolation) with neuronal loss characterize classic CJD. Variant CJD links to BSE exposure themes in public-health vignettes. Unlike slow AD progression over years, prion disease tempo is weeks to months—mechanism of exponential templating, not gradual plaque accumulation alone.
- Entity Key molecular pathology Clinical tempo / focus
- Alzheimer Aβ plaques + tau tangles; cholinergic loss Insidious memory-first dementia
- Frontotemporal Tau or TDP-43 (common); frontal/temporal Behavior or language-first, often younger
- Prion (CJD) Misfolded PrP templating Rapid dementia ± myoclonus, spongiform change
- Movement Disorder Circuit Pearl
Hyperkinetic disorders (chorea, hemiballismus concepts) often reflect loss of inhibitory basal ganglia output control, whereas hypokinetic PD reflects excess braking on thalamocortical motor drive in classic models. Hemiballismus from contralateral subthalamic nucleus lesions removes excitatory drive to the internal pallidum, reducing inhibition of thalamus—an elegant localization that still appears in mechanism questions.
CBSE Integration Approach
For seizures: onset network (focal vs generalized), provocation, and drug channel/GABA target. For movement disorders: which basal ganglia node and which molecule (dopamine, polyQ, copper). For dementia: tempo plus protein (Aβ/tau vs TDP-43/tau FTLD vs prion). That matrix solves most items without memorizing rare eponym lists.